Samrat Pharmachem [SAMRATPH] vs Navin Fluorine [NAVINFLUOR] Detailed Stock Comparison

Samrat Pharmachem

BSE

Navin Fluorine

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Samrat Pharmachem wins in 8 metrics, Navin Fluorine wins in 10 metrics, with 0 ties. Navin Fluorine appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Samrat Pharmachem	Navin Fluorine	Better
P/E Ratio (TTM)	13.81	69.93	Samrat Pharmachem
Price-to-Book Ratio	1.37	9.44	Samrat Pharmachem
Debt-to-Equity Ratio	13.81	55.85	Samrat Pharmachem
PEG Ratio	N/A	0.54	N/A
EV/EBITDA	13.86	40.23	Samrat Pharmachem
Profit Margin (TTM)	1.72%	13.90%	Navin Fluorine
Operating Margin (TTM)	-0.06%	23.65%	Navin Fluorine
EBITDA Margin (TTM)	N/A	23.65%	N/A
Return on Equity	9.91%	10.99%	Navin Fluorine
Return on Assets (TTM)	5.85%	5.97%	Navin Fluorine
Free Cash Flow (TTM)	$-105.99M	$40.40M	Navin Fluorine
Dividend Yield	0.29%	0.39%	Navin Fluorine
1-Year Return	-30.15%	52.80%	Navin Fluorine
Price-to-Sales Ratio (TTM)	0.35	10.03	Samrat Pharmachem
Enterprise Value	$1.08B	$257.61B	Navin Fluorine
EV/Revenue Ratio	0.38	10.10	Samrat Pharmachem
Gross Profit Margin (TTM)	3.39%	57.58%	Navin Fluorine
Revenue per Share (TTM)	$908	$514	Samrat Pharmachem
Earnings per Share (Diluted)	$23.02	$71.47	Navin Fluorine
Beta (Stock Volatility)	-0.32	0.23	Samrat Pharmachem

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Samrat Pharmachem vs Navin Fluorine Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Samrat Pharmachem	-0.91%	-6.16%	-12.87%	-14.81%	-11.45%	-17.63%
Navin Fluorine	-0.40%	2.76%	1.23%	16.74%	24.39%	53.36%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Samrat Pharmachem	-30.15%	-57.38%	181.12%	931.84%	1,575.06%	1,070.42%
Navin Fluorine	52.80%	19.25%	135.76%	1,986.74%	8,408.96%	7,696.81%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Samrat Pharmachem (SAMRATPH): View Full Stock Overview

Navin Fluorine (NAVINFLUOR): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Samrat Pharmachem vs Navin Fluorine

Metric	SAMRATPH	NAVINFLUOR
Market Information
Market Cap i	₹982.37M	₹255.94B
Market Cap Category	Small cap	Large cap
10 Day Avg. Volume i	2,495	81,670
90 Day Avg. Volume i	2,791	129,820
Last Close	₹319.50	₹5,010.50
52 Week Range	₹302.05 - ₹646.00	₹3,160.40 - ₹5,444.00
% from 52W High	-50.54%	-7.96%
All-Time High	₹1,250.00 (Sep 19, 2022)	₹5,444.00 (Jul 31, 2025)
% from All-Time High	-74.44%	-7.96%
Growth Metrics
Quarterly Revenue Growth	-0.06%	0.39%
Quarterly Earnings Growth	-0.14%	1.29%
Financial Health
Profit Margin (TTM) i	0.02%	0.14%
Operating Margin (TTM) i	0.00%	0.24%
Return on Equity (TTM) i	0.10%	0.11%
Debt to Equity (MRQ) i	13.81	55.85
Cash & Liquidity
Book Value per Share (MRQ)	₹232.02	₹529.49
Cash per Share (MRQ)	₹1.70	₹99.88
Operating Cash Flow (TTM) i	₹1.26M	₹4.60B
Levered Free Cash Flow (TTM) i	₹71.12M	₹2.89B
Dividends
Last 12-Month Dividend Yield i	0.29%	0.39%
Last 12-Month Dividend i	₹1.00	₹19.00

Valuation & Enterprise Metrics Analysis: Samrat Pharmachem vs Navin Fluorine

Metric	SAMRATPH	NAVINFLUOR
Price Ratios
P/E Ratio (TTM) i	13.81	69.93
Forward P/E i	N/A	41.36
PEG Ratio i	N/A	0.54
Price to Sales (TTM) i	0.35	10.03
Price to Book (MRQ) i	1.37	9.44
Market Capitalization
Market Capitalization i	₹982.37M	₹255.94B
Enterprise Value i	₹1.08B	₹257.61B
Enterprise Value Metrics
Enterprise to Revenue i	0.38	10.10
Enterprise to EBITDA i	13.86	40.23
Risk & Other Metrics
Beta i	-0.32	0.23
Book Value per Share (MRQ) i	₹232.02	₹529.49

Financial Statements Comparison: Samrat Pharmachem vs Navin Fluorine

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	SAMRATPH	NAVINFLUOR
Revenue/Sales i	₹712.03M	₹7.25B
Cost of Goods Sold i	₹687.86M	₹3.08B
Gross Profit i	₹24.17M	₹4.18B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹-346,000	₹1.72B
EBITDA i	₹185,000	₹2.21B
Pre-Tax Income i	₹-3.64M	₹1.55B
Income Tax i	₹357,000	₹379.40M
Net Income (Profit) i	₹-3.99M	₹1.17B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	SAMRATPH	NAVINFLUOR
Cash & Equivalents i	₹483,000	₹196.80M
Total Current Assets i	₹1.03B	₹15.89B
Total Current Liabilities i	₹495.83M	₹9.15B
Long-Term Debt i	₹0	₹10.67B
Total Shareholders Equity i	₹718.00M	₹26.26B
Retained Earnings i	N/A	₹23.27B
Property, Plant & Equipment i	N/A	₹25.97B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	SAMRATPH	NAVINFLUOR
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	SAMRATPH	NAVINFLUOR
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	2,495	81,670
Average Daily Volume (90 Day) i	2,791	129,820
Shares Outstanding i	3.09M	49.59M
Float Shares i	1.26M	34.85M
% Held by Insiders i	0.59%	0.29%
% Held by Institutions i	0.00%	0.41%

Dividend Analysis & Yield Comparison: Samrat Pharmachem vs Navin Fluorine

Metric	SAMRATPH	NAVINFLUOR
Last 12-Month Dividend i	₹1.00	₹19.00
Last 12-Month Dividend Yield i	0.29%	0.39%
3-Year Avg Annual Dividend i	₹1.67	₹16.33
3-Year Avg Dividend Yield i	0.17%	0.15%
3-Year Total Dividends i	₹5.00	₹49.00
Ex-Dividend Date	Sep 19, 2024	Jul 04, 2025

Samrat Pharmachem [SAMRATPH] vs Navin Fluorine [NAVINFLUOR] Detailed Stock Comparison